SCHEDULE 13G/A 0002033034 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 06/30/2025 0001615165 Veritone, Inc. 92347M100 1615 Platte Street 2nd Floor Denver CO 80202 Rule 13d-1(c) Esousa Group Holdings LLC NY 9928303.00 0.00 9928303.00 0.00 9928303.00 N 9.99 OO Michael Wachs X1 9928303.00 0.00 9928303.00 0.00 9928303.00 N 9.99 IN Veritone, Inc. 1615 Platte Street, 2nd Floor, Denver, CO 80202 Esousa Group Holdings LLC and Michael Wachs. 211 East 43rd Street, Suite 402 New York, NY 10017 Esousa Group Holdings LLC is a New York limited liability company and Mr. Wachs is a U.S. citizen. Y 9,928,303. This amount consists of shares of common stock and shares of common stock issuable upon exercise of pre-funded warrants. This amount reflects the number of shares of common stock that would be issuable upon full exercise of such reported securities and does not give effect to applicable beneficial ownership limitations. Therefore, the actual number of shares of common stock beneficially owned by the Reporting Person, after giving effect to such beneficial ownership limitations, is less than the number of securities reported in this Item 4(a). 9.99%. This percentage is based on 54,005,035 shares of common stock outstanding as of June 27, 2025 plus 6,452,293 shares of common stock issued on June 30, 2025 in a registered direct offering. This percentage assumes the issuance of shares of common stock upon exercise of pre-funded warrants, which are subject to a beneficial ownership limitation of 9.99%, and gives effect to such beneficial ownership limitation. Due to such beneficial ownership limitation, as of the date of the event which requires the filing of this statement, the Reporting Person could not exercise all of the pre-funded warrants. 9,928,303. See Item 4(a). 0 9,928,303. See Item 4(a). 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G Esousa Group Holdings LLC /s/ Michael Wachs 07/15/2025 Michael Wachs /s/ Michael Wachs 07/15/2025